Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

701
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
701
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

4.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.1K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

1.5K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.5K
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

505
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
505
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

652
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
652
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

5.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lack of association between second-degree tears and pelvic floor symptoms one year postpartum.

Acta obstetricia et gynecologica Scandinavica·2026
Same author

Assisted Reproductive Technology and Cardiovascular Outcomes in Women: A Systematic Review and Meta-Analysis.

Journal of clinical medicine·2026
Same author

Stevens-Johnson syndrome and toxic epidermal necrolysis in pregnancy.

The British journal of dermatology·2026
Same author

The effect of meeting Canada's 24-hour movement guidelines on the severity of symptoms of generalized anxiety disorder: A target trial emulation from a longitudinal study.

Journal of affective disorders·2026
Same author

Severe maternal morbidity and re-hospitalisation in the first postpartum year within Canada, 2008-2020: a population-based retrospective cohort study.

BMJ public health·2026
Same author

Two decades of change: The evolution of Canadian public health organizations in chronic disease prevention, 2004-2023.

Canadian journal of public health = Revue canadienne de sante publique·2026

Related Experiment Video

Updated: Mar 16, 2026

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
05:31

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

1.5K

Recurrent pre-eclampsia and subsequent cardiovascular risk.

Nathalie Auger1,2, William D Fraser3, Mireille Schnitzer4

  • 1Institut national de santé publique du Québec, Montreal, Québec, Canada.

Heart (British Cardiac Society)
|August 18, 2016
PubMed
Summary
This summary is machine-generated.

Recurrent pre-eclampsia significantly increases the risk of long-term cardiovascular hospitalisation and hastens the time to cardiovascular events. Early cardiovascular screening is recommended for women with recurrent pre-eclampsia.

More Related Videos

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System
07:34

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System

Published on: May 5, 2018

12.4K
Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
12:02

Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption

Published on: July 30, 2016

16.6K

Related Experiment Videos

Last Updated: Mar 16, 2026

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
05:31

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

1.5K
Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System
07:34

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System

Published on: May 5, 2018

12.4K
Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
12:02

Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption

Published on: July 30, 2016

16.6K

Area of Science:

  • Obstetrics and Gynecology
  • Cardiology
  • Public Health

Background:

  • Pre-eclampsia is a pregnancy complication associated with increased cardiovascular risk.
  • The long-term cardiovascular implications of recurrent pre-eclampsia require further investigation.

Purpose of the Study:

  • To determine the association between recurrent pre-eclampsia and long-term cardiovascular hospitalisation.
  • To assess the incidence, timing, and risk of cardiovascular complications following pre-eclampsia.

Main Methods:

  • A population-based cohort study in Québec, Canada, identified cardiovascular hospitalisations up to 25 years post-pregnancy.
  • Included women with two or more deliveries (recurrent/non-recurrent pre-eclampsia) and women with one delivery (pre-eclampsia).
  • Accelerated failure time models adjusted for confounders were used to calculate incidence and risk.

Main Results:

  • Women with recurrent pre-eclampsia had a higher incidence of cardiovascular hospitalisation (281.4/1000) compared to non-recurrent (167.7/1000) or no pre-eclampsia (72.6/1000).
  • Recurrent pre-eclampsia was linked to a 2-fold risk of heart disease and a 3-fold risk of cerebrovascular disease.
  • Mean time to cardiovascular hospitalisation was shorter for women with recurrent pre-eclampsia (10.5 years) versus no pre-eclampsia (12.7 years).

Conclusions:

  • Recurrent pre-eclampsia is associated with a significantly higher risk and earlier onset of future cardiovascular hospitalisation.
  • These findings underscore the need for earlier and more intensive cardiovascular screening in women with a history of recurrent pre-eclampsia.